News
After a drawn-out acquisition ... U.K. biotech F-star Therapeutics is charting its own path as a private, independent company. The antibody-focused biotech is breaking free from invoX Pharma ...
Company Logo Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2024" report has been added to ...
Hosted on MSN6mon
Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?The introduction of COVID-19 vaccinations in 2020 caused the biotech industry to soar to prominence. As Big Pharma started investing in acquisitions, investor interest increased in late 2023 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results